DANA RUNDLE's Listings [1]
Send Peer Request
Abstract
1.
Member Organization : Oklahoma
SHetA2 is the first compound of its kind to pass National Cancer Insititute pre-clinical testing and is available for FDA in-human trials for the prevention of ovarian cancer. However, SHetA2 may function poorly in human clinical trials and analogs...

Contact Oklahoma Researcher
Copyright © 2008-2017 ResearchAccelerator.org, all rights reserved